Dapagliflozin tends to slow down chronic kidney disease and IgA nephropathy. Dapagliflozin is a generic drug for Farxiga, which recently was approved. The research shows that this medication helps slow down 71% of GFR decline, which is very important for
When you have chronic kidney disease, preserving what little kidney function remains is of critical importance. A recent study by Tokyo Takanawa hospital’s Dr. Kenjiro Kimura followed a group of elderly CKD patients who were split into two groups, one
